Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended August 31, 1994, for National Medical Enterprises, Inc. (NME). The company operates acute care hospitals and related facilities. The reporting period is characterized by the ongoing divestiture of its psychiatric hospital business, the sale of its renal dialysis subsidiary, and the announcement of a definitive merger agreement with American Medical Holdings, Inc. (AMH).
Key Financial Metrics
| Metric | Q1 1995 (Ended Aug 31, 1994) | Q1 1994 (Ended Aug 31, 1993) |
|---|---|---|
| Net Operating Revenues | $662,835,000 | $771,554,000 |
| Net Income | $64,028,000 | $(40,780,000) |
| Income from Continuing Operations | $64,028,000 | $52,728,000 |
| Earnings Per Share (Diluted) | $0.36 | $(0.25) |
| Cash and Cash Equivalents | $112,304,000 | $175,659,000 |
| Net Cash Used in Operating Activities | $(377,211,000) | $79,226,000 |
| Total Debt to Equity Ratio | 0.61:1 | N/A |
| Working Capital | $(123,695,000) Deficit | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net operating revenues decreased 14% to $662.8 million, primarily due to the sale of 28 physical rehabilitation hospitals and 45 outpatient clinics in the prior fiscal year.
- Profitability Improvement: Despite lower revenues, operating profit margins improved from 11.0% to 12.8% due to cost control programs and the sale of lower-margin rehabilitation facilities.
- Discontinued Operations: The prior year included a $153.6 million loss from discontinued psychiatric operations. The current quarter shows no loss from discontinued operations as the business is being phased out.
- Cash Flow: Operating cash flow turned negative ($377.2 million used) compared to a positive $79.2 million in the prior year. This was driven by $379.6 million in payments for settlements of government investigations related to the psychiatric division.
- Asset Sales: Proceeds from sales of facilities and investments totaled $157.6 million, including the sale of 34 psychiatric hospitals and two general hospitals.
Guidance, Outlook, and Material Events
- Merger with AMH: On October 11, 1994, NME announced a definitive merger with American Medical Holdings, Inc. valued at over $3.3 billion. The deal involves a cash and stock exchange and is expected to close in early 1995. Financing will include a new $2 billion credit facility and $900 million in debt securities.
- Renal Dialysis Sale: NME sold a controlling interest in Total Renal Care, Inc., recognizing a $32 million gain while retaining a 25% minority interest.
- Restructuring: A $77 million restructuring charge was taken in the prior quarter for overhead reduction. Actual costs incurred in this quarter were $2.97 million, with expected annual savings of $32 million.
- Liquidity and Debt: The company faces a working capital deficit and significant debt maturing in April 1995. Management is negotiating a new $2 billion credit facility to refinance this debt and fund the AMH merger.
- Legal Contingencies: Reserves of $75.1 million remain for unsettled litigation related to the psychiatric business. Management estimates $63 million of this will be paid within one year.
Investor Verification Checklist
- Verify the status and regulatory approval timeline for the $3.3 billion merger with American Medical Holdings, Inc.
- Confirm the execution of the new $2 billion credit facility required to refinance debt maturing in April 1995.
- Monitor the final settlement amounts for the psychiatric division litigation against the $75.1 million reserve.
- Track the completion of the remaining psychiatric hospital sales to Charter Medical Corporation and other parties.
- Assess the impact of the 14% revenue decline on future operating margins as the company transitions to a smaller, acute-care-focused portfolio.